The Impact of the COVID-19 Pandemic on Tobacco Treatment Program Implementation at National Cancer Institute-Designated Cancer Centers
Rattachement africain : us. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
INTRODUCTION: The COVID-19 pandemic disrupted cancer screening and treatment delivery, but COVID-19's impact on tobacco cessation treatment for cancer patients who smoke has not been widely explored. AIMS AND METHODS: We conducted a sequential cross-sectional analysis of data collected from 34 National Cancer Institute (NCI)-designated cancer centers participating in NCI's Cancer Center Cessation Initiative (C3I), across three reporting periods: one prior to COVID-19 (January-June 2019) and two during the pandemic (January-June 2020, January-June 2021). Using McNemar's Test of Homogeneity, we assessed changes in services offered and implementation activities over time. RESULTS: The proportion of centers offering remote treatment services increased each year for Quitline referrals (56%, 68%, and 91%; p = .000), telephone counseling (59%, 79%, and 94%; p = .002), and referrals to Smokefree TXT (27%, 47%, and 56%; p = .006). Centers offering video-based counseling increased from 2020 to 2021 (18% to 59%; p = .006), Fewer than 10% of centers reported laying off tobacco treatment staff. Compared to early 2020, in 2021 C3I centers reported improvements in their ability to maintain staff and clinician morale, refer to external treatment services, train providers to deliver tobacco treatment, and modify clinical workflows. CONCLUSIONS: The COVID-19 pandemic necessitated a rapid transition to new telehealth program delivery of tobacco treatment for patients with cancer. C3I cancer centers adjusted rapidly to challenges presented by the pandemic, with improvements reported in staff morale and ability to train providers, refer patients to tobacco treatment, and modify clinical workflows. These factors enabled C3I centers to sustain evidence-based tobacco treatment implementation during and beyond the COVID-19 pandemic. IMPLICATIONS: This work describes how NCI-designated cancer centers participating in the Cancer Center Cessation Initiative (C3I) adapted to challenges to sustain evidence-based tobacco use treatment programs during the COVID-19 pandemic. This work offers a model for resilience and rapid transition to remote tobacco treatment services delivery and proposes a policy and research agenda for telehealth services as an approach to sustaining evidence-based tobacco treatment programs.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- The Impact of the COVID-19 Pandemic on Tobacco Treatment Program Implementation at National Cancer Institute-Designated Cancer Centers
- Date Crossref
- 02/07/2022
- Éditeur
- Oxford University Press (OUP)
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
University of Wisconsin–Madison pays non établi dans la noticeUniversité ou école supérieure
-
University of Wisconsin Carbone Cancer Center pays non établi dans la noticeOrganisme public
-
University of North Carolina at Chapel Hill pays non établi dans la noticeUniversité ou école supérieure
-
UNC Lineberger Comprehensive Cancer Center pays non établi dans la noticeÉtablissement de santé
-
Georgetown University pays non établi dans la noticeUniversité ou école supérieure
-
Georgetown University Medical Center pays non établi dans la noticeÉtablissement de santé
-
Memorial Sloan Kettering Cancer Center pays non établi dans la noticeÉtablissement de santé
-
Virginia Commonwealth University Department of Psychiatry pays non établi dans la noticeUniversité ou école supérieure
-
Moffitt Cancer Center pays non établi dans la noticeÉtablissement de santé
-
The State University of New Jersey Rutgers pays non établi dans la noticeUniversité ou école supérieure
-
Rutgers Cancer Institute pays non établi dans la noticeÉtablissement de santé
-
Massachusetts General Hospital Department of Psychiatry pays non établi dans la noticeÉtablissement de santé
University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center et University of North Carolina at Chapel Hill, avec 9 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.